Lyme borreliosis: tick bite, erythema migrans, disseminated forms
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Tick bite or erythema migrans: no tests
- No Lyme serology after a tick bite, nor for erythema migrans: the diagnosis of erythema migrans is clinical and it is treated without tests.
Do not order
Suspected disseminated form (neurological, joint, late skin, cardiac, ocular)
Laboratory tests
- Lyme serology: ELISA, then Western blot at the laboratory's initiative if positive or equivocal (state tick exposure and clinical signs)
3 weeks later
- Repeat Lyme serology (if negative and symptoms for less than 6 weeks)if neededStrong suspicion of early disseminated disease, negative serology and symptoms present for less than 6 weeks: repeat the test 3 weeks later to look for seroconversion [1].
Do not order
- Follow-up serology after treatment: no serological follow-up is recommended, cure is judged on clinical grounds and raised antibodies can persist for years [1].
- Lyme serology in diffuse, migratory arthromyalgia without arthritis or other suggestive sign [1], or in an isolated psychiatric manifestation [1].
- C6-EIA tests, microfluidic methods and any test other than serology, intrathecal synthesis, PCR and CXCL13: not recommended in routine practice [1].
- Borrelia PCR in blood or urine: not recommended, its sensitivity there is almost nil [1].
- Western blot straight away, without ELISA: serology starts with ELISA, Western blot is done only if ELISA is positive or equivocal [1,6].
Persistent symptoms after treated borreliosis
Laboratory tests guided by symptoms (not routine)
- FBCif neededTests proposed as non-routine by the HAS, to be chosen according to symptoms, to exclude a differential diagnosis [2].
- CRPif neededTests proposed as non-routine by the HAS, to be chosen according to symptoms, to exclude a differential diagnosis [2].
- Serum electrolytes, serum creatinine, liver function tests, fasting plasma glucoseif neededAccording to symptoms, to exclude a differential diagnosis [2].
- Serum ferritinif neededAccording to symptoms (fatigue in particular) [2].
- serum protein electrophoresisif neededAccording to symptoms (fatigue in particular) [2].
- Creatine kinase (CK)if neededMyalgia, polyalgia or weakness: according to symptoms [2].
- LDHif neededMyalgia, polyalgia or weakness: according to symptoms [2].
- Serum calciumif neededMyalgia, polyalgia or weakness: according to symptoms [2].
- Serum phosphateif neededMyalgia, polyalgia or weakness: according to symptoms [2].
- TSHif neededThe HAS cites a “hormonal work-up” guided by symptoms, without detailing it [2].
Do not order
- Repeat Lyme serology to “check cure” or explain persistent symptoms: high titres persist for years and must not lead to treatment being restarted [1].
Sources (6)
- Haute Autorité de santé. Borréliose de Lyme et autres maladies vectorielles à tiques (MVT). Recommandation de bonne pratique, adoptée par le Collège le 13 février 2025 (actualisation complète de la recommandation de 2018).
- Haute Autorité de santé. Borréliose de Lyme et autres maladies vectorielles à tiques (MVT) : toutes les fiches pratiques. Février 2025.
- National Institute for Health and Care Excellence. Lyme disease. NICE guideline NG95, publiée le 11 avril 2018, dernière mise à jour le 17 octobre 2018.
- Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis. 2021;72(1):e1-e48.
- Robert Koch-Institut (Allemagne). RKI-Ratgeber Lyme-Borreliose. Version actualisée d'avril 2019, section « Vorkommen » adaptée en avril 2025.
- Caisse nationale de l’assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1301 et 1302 (borréliose de Lyme).